» Articles » PMID: 28576906

Factors Associated with Frailty and Its Trajectory Among Patients on Hemodialysis

Overview
Specialty Nephrology
Date 2017 Jun 4
PMID 28576906
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Frailty is common among patients on hemodialysis and associated with adverse outcomes. However, little is known about changes in frailty over time and the factors associated with those changes.

Design, Setting, Participants, & Measurements: To address these questions, we examined 762 participants in the A Cohort to Investigate the Value of Exercise/Analyses Designed to Investigate the Paradox of Obesity and Survival in ESRD cohort study, among whom frailty was assessed at baseline and 12 and 24 months. We used ordinal generalized estimating equations analyses and modeled frailty (on a scale from zero to five possible components) and death during follow-up.

Results: The mean frailty score at baseline was 1.9, and the distribution of frailty scores was similar at each evaluation. However, most participants' scores changed, with patients improving almost as often as worsening (overall change, 0.2 points per year; 95% confidence interval, 0.1 to 0.3). Hispanic ethnicity (0.6 points per year; 95% confidence interval, 0.0 to 1.1) and diabetes (0.7 points per year; 95% confidence interval, 0.3 to 1.0) were associated with higher frailty scores and higher serum albumin concentration with lower frailty scores (-1.1 points per g/dl; 95% confidence interval, -1.5 to -0.7). In addition, patients whose serum albumin increased over time were less likely to become frail, with each 1-g/dl increase in albumin associated with a 0.4-point reduction in frailty score (95% confidence interval, -0.80 to -0.05). To examine the underpinnings of the association between serum albumin and frailty, we included serum IL-6, normalized protein catabolic rate, and patient self-report of hospitalization within the last year in a second model. Higher IL-6 and hospitalization were statistically significantly associated with worse frailty at any point and worsening frailty over time, whereas normalized protein catabolic rate was not independently associated with frailty.

Conclusions: There was substantial year to year variability in frailty scores, with approximately equal numbers of patients improving and worsening. Markers of inflammation and hospitalization were independently associated with worsening frailty. Studies should examine whether interventions to address inflammation or posthospitalization rehabilitation can improve the trajectory of frailty.

Citing Articles

Gait Speed and All-Cause Mortality in Whole-Spectrum Chronic Kidney Disease: A Systematic Review and Meta-Analysis Included 6217 Participants.

Zhang F, Wang H, Bai Y, Huang L, Zhong Y, Li Y J Cachexia Sarcopenia Muscle. 2025; 16(1):e13739.

PMID: 39991779 PMC: 11848591. DOI: 10.1002/jcsm.13739.


The prevalence of frailty among older adults with maintenance hemodialysis: a systematic.

Li J, Xiao W, Wang L, Zhang M, Ge Y BMC Nephrol. 2025; 26(1):10.

PMID: 39794749 PMC: 11724589. DOI: 10.1186/s12882-024-03921-3.


Construction of frailty and risk prediction models in maintenance hemodialysis patients: a cross-sectional study.

Liu H, Tao M, Zhang M, Zhou Z, Ni Y, Wang Q Front Med (Lausanne). 2024; 11:1296494.

PMID: 39440043 PMC: 11494607. DOI: 10.3389/fmed.2024.1296494.


Longitudinal frailty assessment in the prediction of survival among patients with advanced chronic kidney disease: a prospective observational single-centre cohort study.

Kennard A, Richardson A, Rainsford S, Hamilton K, Glasgow N, Pumpa K BMJ Open. 2024; 14(10):e087189.

PMID: 39389597 PMC: 11474908. DOI: 10.1136/bmjopen-2024-087189.


How to make a shared decision with older persons for end-stage kidney disease treatment: the added value of geronto-nephrology.

Guerville F, Pepin M, Garnier-Crussard A, Beuscart J, Citarda S, Hocine A Clin Kidney J. 2024; 17(10):sfae281.

PMID: 39372237 PMC: 11450468. DOI: 10.1093/ckj/sfae281.